Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA355959
Max Phase: Preclinical
Molecular Formula: C15H23N3O10
Molecular Weight: 405.36
Molecule Type: Small molecule
Associated Items:
ID: ALA355959
Max Phase: Preclinical
Molecular Formula: C15H23N3O10
Molecular Weight: 405.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC[C@H]1O[C@@H](OC(CO)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C15H23N3O10/c16-3-5-8(21)11(24)14(26-5)27-6(4-19)12-9(22)10(23)13(28-12)18-2-1-7(20)17-15(18)25/h1-2,5-6,8-14,19,21-24H,3-4,16H2,(H,17,20,25)/t5-,6?,8-,9+,10-,11-,12-,13-,14+/m1/s1
Standard InChI Key: CSZXHEFWJRKHDV-ISCGUFRQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 405.36 | Molecular Weight (Monoisotopic): 405.1383 | AlogP: -5.06 | #Rotatable Bonds: 6 |
Polar Surface Area: 209.72 | Molecular Species: BASE | HBA: 12 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.70 | CX Basic pKa: 8.75 | CX LogP: -4.58 | CX LogD: -5.70 |
Aromatic Rings: 1 | Heavy Atoms: 28 | QED Weighted: 0.24 | Np Likeness Score: 1.53 |
1. Dini C, Drochon N, Feteanu S, Guillot JC, Peixoto C, Aszodi J.. (2001) Synthesis of analogues of the O-beta-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 1: contribution of the amino group and the uracil moiety upon the inhibition of MraY., 11 (4): [PMID:11229763] [10.1016/s0960-894x(00)00715-0] |
Source(1):